TEMPORARILY NO VALUATION. (previous: not rated)

Similar documents
Electronics Line 3000 Ltd.

NOT RATED. (previously Buy) (previously 1.73) adj. net (mln ) DPS ( ) adj. EPS ( )

Evaluation result Fair value DPS. adj. net. adj. EPS ( )

PA Power Automation AG

Evaluation result Fair value BUY (prev.: BUY) (prev.: 21.52)

PA Power Automation AG

HOLD 51,85. (previous: Hold) (previous: 51,65)

BUY (previous: BUY) (previous: 77.50)

BUY (previous: BUY) (previous: 3.70)

HOLD (previous: BUY) (previous: 68.00)

- 2/7 - Segment Discussion August 05, Segment Discussion. Stock and Valuation

HOLD (previous: Hold) (previous: 51.85)

All for One Steeb AG August 13, 2013

Evaluation Result Fair Value BUY (previous: BUY) (previous: 65.50)

BUY (previous: BUY) (previous: 2.20)

BUY (previous: BUY) (previous: 3.40)

BUY (previous: BUY) (previous: 72.30) DPS ( ) adj. EPS ( )

BUY (previous: BUY) (previous: 75.65)

Key ratios Sales adj. net

Buy PT EUR24,00, upside 23%

Financials/Prime Standard

Borussia Dortmund GmbH & Co. KGaA

PLEASE CONSIDER IMPORTANT INFORMATION, DISCLOSURES AND THE DISCLAIMER AT THE END OF THIS DOCUMENT!

Solid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment

Research Note. Fair Value REIT-AG

Klaus Kränzle, Please inform yourself of important disclosures and disclaimers in the appendix

Price Target: EUR 4.15 (3.80)

BDI BioEnergy Internat Buy

Borussia Dortmund GmbH & Co. KGaA

ISRA VISION Neutral

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation

Buy PT 24,00, upside 23%

Advanced Vision Techn Buy

EQUINET INVESTIGATOR

Price Target: EUR (22.00)

PrimeCity Investment Plc

Geratherm Medical AG Strong demand in Q3

Price Target: EUR (20.00) 04 April 2012 FY11 results: No surprises so far

CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A

Price Target: EUR (17.00)

Price Target: EUR (20.60) 07 April 2011 Solid FY10 & More to come

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F

Tel.: +49 (0) Tel.: +49 (0)

Indygotech Minerals S.A.

adesso AG MAY 31, 2012

Reduced EPS but smart acquisition

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research

Intershop Communications AG

18 October 2016 aventron AG. FIRST BERLIN Equity Research

6 September 2016 aventron AG. FIRST BERLIN Equity Research

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research

GOING EAST & ONE YEAR AFTER

adesso AG November 5, 2012

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research

Price Target: EUR 1.30 (1.30)

Borussia Dortmund GmbH & Co KGaA

Price Target: EUR (50.00)

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview

Buy. Straumann Price CHF (Closing price as of ) Applied disclosures can be found in the appendix

co.don AG Q1 substantially above last year 13 April 2015

Price target: EUR (20.00) 15 August 2014 Final 2Q figures match preliminary figures

26 April 2017 aventron AG. FIRST BERLIN Equity Research

Sandpiper Digital Payments AG

Price Target: EUR 5.00 (5.00)

18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research

14 September 2017 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 216.5% ISIN: NL

Price Target: EUR 1.60 (1.50)

ad pepper media International N.V.

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A

18 January 2018 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 45.9% ISIN: NL

Borussia Dortmund GmbH & Co. KGaA

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS

Petro Rabigh Shutdown marred Q2 results

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research

SABIC Overall strong performance

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research

6 June 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 44.2% ISIN: DE000A1EWVY8

Aroundtown SA LATEST RUN RATES CONFIRM GROWTH PHASE. FIRST BERLIN Equity Research. Operational PRICE TARGET Ar ou

Yansab Better than expected results

Leifheit AG. Management Meeting confirms our positive view. Buy (Buy) EUR (60.00 EUR ) BANKHAUS LAMPE // 1 16/02/2016

Zain KSA bogged down by high debt

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

Advanced Vision Technology

Mensch und Maschine SE

Alcomet 1Q 2011 Report 28 June 2011

Borussia Dortmund GmbH & Co KGaA

Schloss Wachenheim AG

Price Target: EUR (35.00)

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research

!""(old: EUR 20.90) This report is intended for Unauthorized redistribution of this report is prohibited.

SPEEDY INDUSTRY: COURIER SERVICES RESULTS ANALYSIS GAINING MOMENTUM RECOMMENDATION: HOLD PREVIOUS RECOMMENDATION: BUY

Adler Real Estate AG. Fewer vacancies, more properties. Buy (Buy) EUR (16.50 EUR ) BANKHAUS LAMPE // 1 28/03/2017

Ahluwalia Contracts (India)

11 January 2018 Deutsche Rohstoff AG. FIRST BERLIN Equity Research. Update. Bloomberg: DR0 GR Return Potential 40.2% ISIN: DE000A0XYG76

Transcription:

23. Dezember 2013 Information analysis Analysts Dr. Roger Becker, CEFA David Szabadvari +49 69 71 91 838-46, -48 roger.becker@bankm.de, david.szabadvari@bankm.de Valuation Result TEMPORARILY NO VALUATION (previous: not rated) Fair Value n.a. Restructuring in Phase 2 - Focus on securing Liquidity Sector WKN Special Chemistry 760860 In line with our expectation, the operating result at the end of Q3 is still weak. Given the short time for implementation, first positive results emerging from the restructuring process will materialize not until the end of the year. Key elements of the already initiated restructuring program are the realization of cost saving potentials e.g. by means of consolidation of locations as well as through a focus on market segments characterized by above-average growth such as private label and liquid detergents. Still, the liquidity situation is a matter of concern which is being clearly identified by the Company s management in the context of its quarterly report. More specifically, it is the method of financing through short term credit lines which are currently compensating for the negative operating cash flow. Therefore, a moratorium with the financial institutions has been put in place until the end of the fiscal year providing scope for negotiations of a sustainable financing concept. The amount outstanding in the context of the capital increase in June 2013, which was completely subscribed for by the principal shareholder, was fully paid in during Q3; this entailed a strengthening of the equity base during the 9M reporting period by 10 mln and resulted in an equity ratio of 22.7%. ISIN Bloomberg/Reuters Accounting standard Financial year Financial reporting 2013 DE0007608606 H4G GY/H4GG.DE IFRS Dec 31 Apr 30, 2014 Market segment Transparency standard Regulated Market Prime Standard Financial ratios 2010a 2011a 2012a EV/Sales 0.7 0.6 0.6 EV/EBITDA 11.2 8.7 9.2 EVEBIT 23.7 18.1 35.7 P/E adj. 55.5 17.8 126.2 Price/Bookvalue 1.9 1.5 1.5 Price/FCF neg. neg. neg. ROE (in %) 0.9 2.2 0.3 Dividend yield (in %) 0.0 3.1 0.0 Number of shares outs. (in ths) 51.5 MarketCap / EV (in mln) 74,1 / 183,2 Given the still continuing restructuring measures, we continue to refrain from a valuation of the stock. Free float (in %) 60,0 Ø daily trading vol. (3m, in ) 32,597 12 months high/low (in ; XETRA-close) 3,55 / 1,06 Price Dec 20, 2013 (in ; XETRA-close) 1.44 Key Earnings Figures Year Sales EBITDA EBIT EBT Net Profit EPS ( ) DPS ( ) EBIT- Margin Net- Margin 2010a 356.1 21.6 10.2 5.8 3.3 0.07 0.00 2.9% 0.9% 2011a 383.5 25.6 12.2 6.4 4.2 0.18 0.10 3.2% 1.1% 2012a 398.8 26.3 6.7 1.1 1.1 0.02 0.00 1.7% 0.3% 9M2013a 250.9-3.8-13.6-18.4-18.1-0.35 0.00 neg. neg. Source: HANSA GROUP AG, BankM Research Performance 1M 6M 12M absolute (in %) -7.2-53.4-45.5 relative (in %) -9.6-59.4-55.0 Benchmark index Daxsubsec. All Chemicals Specialty HANSA GROUP AG (red/light), Performance 1 year vs. Daxsubsec. All Chemicals, Specialty Performance (black/dark) Source: Bloomberg This document has been prepared due to a service agreement with the respective issuer. BankM Repräsentanz der biw AG is the designated sponsor of the company s stock and in this function as a designated sponsor regularly holds a trading stock or long or short positions in the company s stock. Equity investments generally involve high risks. Potential investors should take into account that share prices may fall and rise and that income from an investment may fluctuate considerably. Investors may lose some or all of the money invested. Investors make their decisions at their own risk. biw Bank für Investments und Wertpapiere AG, Willich, is responsible for the preparation of this document.

- 2/8 - Financial Analysis 23. Dezember 2013 Financial Analysis - First 9 months of 2013 - The group of companies included in the consolidated financial statements of the Hansa Group comprises HANSA GROUP AG, Genthin, Chemische Fabrik WIBARCO GmbH (since 2007), Waschmittelwerk Genthin GmbH (since 2009) and Luhns GmbH (since 2010). Sale of the commercial segment and Schlecker insolvency have pushed down sales Income Statement Following the sale of the commercial division, the business activities of HANSA GROUP AG are now divided into the two operating segments 1. Consumer Products (laundry detergents, cleaning agents, personal care products) 2. Chemicals (surfactants and precursors and intermediate products thereof) In the first nine months of the current financial year, sales at the Group level fell by 22.8% from 325.0 mln to 250.9 mln. This fall was largely attributable to the loss of the trading segment. The earnings before interest and taxes (EBIT) amounted to -13.6 mln and was thus significantly lower than in the previous year ( 11.9 mln). However, comparability is limited due to the sale of the trading segment last year which entailed an extraordinary gain. The earnings after taxes amounted to -18.1 mln, or -0.35 per share (previous year: 0.12 per share). Segment analysis During the reporting period, 44% ( 110.1 mln) of total consolidated sales were generated by the Consumer Products segment, and 56% ( 140.9 mln) by the Chemicals segment, with the share of total sales represented by retail products increasing significantly by 10% ppts. - at the expense of the Chemicals segment - as compared to the previous year. The majority of the Group s sales are generated in Germany and the European Community; Other foreign countries, with a 15% share of overall sales, have assumed more of a backseat role as a result of the sale of the trading division with its more international focus. Geographical Distribution of Segment Sales Others 15% Europ. Union (ex D) 36% Germany 49% Source: HANSA GROUP AG

23. Dezember 2013 Financial Analysis - 3/8 - Income Statement Fiscal Year 31.12 (IFRS) 2010a 2011a 2012a 9M/2012 9M/2013 in T Total Sales 356,140 383,459 398,801 325,010 250,946 Other operating income 14,475 4,085 31,265 6,652 3,608 Changes in inventory 1,136 3,122-6,932 2,480-1,583 Other own work capitalized 757 1,842 426 422 2 Cost of materials 269,258 274,500 301,587 232,689 191,222 in % of total sales 75.6 71.6 75.6 71.6 76.2 Personnel expenses 30,828 34,972 33,319 25,897 24,060 in % of total sales 8.7 9.1 8.4 8.0 9.6 Other operating expenses 50,851 57,485 62,366 48,779 41,449 EBITDA 21,570 25,551 26,287 27,199-3,757 in % of total sales 6.1 6.7 6.6 8.4-1.5 Depreciation and amortization 11,355 13,320 19,539 15,290 9,849 in % of total sales 3.2 3.5 4.9 4.7 3.9 EBIT 10,215 12,232 6,748 11,910-13,607 in % of total sales 2.9 3.2 1.7 3.7-5.4 Interest income 1,316 98 733 64 929 Interest expense 5,699 5,763 6,342 4,144 5,686 Writedowns on financial assets 0 130 0 0 0 EBT 5,832 6,436 1,139 7,829-18,363 in % of total sales 1.6 1.7 0.3 2.4-7.3 Taxes on Income (Exp.+/Inc.-) 2,581 2,208-4 2,228-264 Net profit 3,251 4,228 1,143 5,602-18,099 in % of total sales 0.9 1.1 0.3 1.7-7.2 Adjustements 0.0 4,216.0 0.0 0.0 0.0 Adjusted net profit 3,251 8,444 1,143 5,602-18,099 in % of total sales 0.9 2.2 0.3 1.7-7.2 No. of shares (Ø outstanding) 48,078 48,078 48,078 48,078 51,503 Net profit / share (EPS) 0.07 0.09 0.02 0.12-0.35 Adj. net profit / share (adj. EPS) 0.07 0.18 0.02 0.12-0.35 Source: HANSA GROUP AG, BankM Research Cash Flow Statement Changes in cash and cash equivalents having an effect on cash flow amounted to -11.5 mln as of the balance sheet date (September 30, 2013). These primarily related to negative operating cash flow in the amount of -13.9 mln and the repayment of loans in the amount of 7.0 mln, which could be serviced as a result of the capital increase. The proceeds from the capital increase are now fully paid in at the amount of 10 mln, hence the account receivable of 4.8 mln, still outstanding at the end of Q2, was released. Total cash and cash equivalents amounted to -29.1 mln as of the end of the first nine months of 2013. Liquidity is ensured by means of cash inflows from advance financing of liabilities (reverse factoring), structured ABS products and drawdowns on overdraft facilities. The Company has credit lines in the amount of 36.6 mln at its disposal, the Company s available liquidity amounts to 7.6 mln as of September 30, 2013. We would like to point out that payment of the overdrafts could fall due on short notice and thus give rise to a strain on liquidity. On the whole, we do not consider Cash and cash equivalents 9M2013: -29.1 mln; available liquidity: 7.6 mln

- 4/8 - Financial Analysis 23. December 2013 this form of external financing to be efficient in the long term and thus assume that the Company s management board will in the medium term endeavor to reduce the amount of the overdrafts, possibly by means of further equity financing measures and/or medium- to long-term debt instruments, with a view to managing potential liquidity shortages. Therefore, a moratorium with the financial institutions has been put in place until the end of the fiscal year providing scope for negotiations of a sustainable financing concept. We believe that the restructuring measures will bring about improvements in the Company s cost structures, which will in turn boost its liquidity. Cash Flow Statement Fiscal Year 31.12 (IFRS) 2010a 2011a 2012a 9M/2012 9M/2013 in T Net profit 3,251 4,228 1,143 5,602-18,099 + Depreciation and amortization 11,355 13,320 19,539 15,290 9,849 + Chg. in long-term provisions 2,268-1,341-1,540 3,179-1,902 = Cash Earnings 16,874 16,206 19,142 24,070-10,152 +/- Other non-cash items -9,255-1,639-37,245-111 -1,091 - Chg. in net working capital -22,312 2,741 323 38,196 4,319 - taxes paid 0 11,053 2,392-2,220 480 = Operating Cash Flow 29,931 775-20,817-11,795-13,861 - Capex 31,866 21,216 4,544-1,133 663 = Free Cash Flow -1,934-20,442-25,361-10,662-14,524 + Other net items 0 11,355 5,000-6,355 0 - Dividends (previous year) 0 0 4,808 4,808 0 + Increase in share capital 0 0 0 0 10,000 +/- Bank loans 28,494 3,371-2,166-9,481-6,977 = Incr. in Cash (+)/Decr. in Cash (-) 26,560-5,716-27,335-31,305-11,500 Source: HANSA GROUP AG, BankM Research Fall in balance sheet total to 372 mln, insufficient equity-tofixed-assets ratio Balance Sheet The balance sheet total fell by 8% from 405 mln to 372 mln. The equity-tofixed-assets ratio is insufficient: only 73% of the non-current fixed assets is covered by long-term capital. This makes it necessary to further strengthen the equity base and, preferably, to replace very short-term financing instruments with longer-term debt. Equity ratio of 22.7% The equity ratio has fallen from 23.1% to 22.7% and as such is significantly below the industry average, which in recent years has consistently been between 31.7% (2010) and 35.0% (2011). The abovementioned restructuring measures could contribute to improving the balance sheet performance.

23. Dezember 2013 Financial Analysis - 5/8 - Balance Sheet Fiscal Year 31.12 (IFRS) 2010a 2011a 2012a 31.12.2013 9M/2013 in T Assets Tangible assets 208,209 217,325 202,823 202,823 195,138 Intangible assets 45,556 43,105 39,839 39,839 38,343 Deferred tax 931 2,148 540 540 512 Other fixed assets 1,294 1,308 28,422 28,422 28,909 Total Fixed Assets 255,990 263,886 271,623 271,623 262,900 Inventories 42,115 41,396 31,680 31,680 27,517 Accounts receivable 23,595 36,613 44,083 44,083 46,680 Total liquid funds 27,045 34,125 22,126 22,126 7,640 Other current assets 22,864 29,744 35,546 35,546 26,982 Total Current Assets 115,620 141,878 133,435 133,435 108,819 Balance Sheet Total 371,611 405,764 405,058 405,058 371,720 Shareholder's Equity / Liabilities Subscribed capital 48,078 48,078 48,078 48,078 51,503 Share premium 6,532 6,532 6,532 6,532 13,107 Retaine earnings 39,367 43,864 38,850 38,850 19,738 Shareholders Equity 93,976 98,474 93,460 93,460 84,348 Long term liabilities 97,291 104,431 107,077 116,050 117,552 t/o Provisions 8,689 8,434 10,300 10,300 11,976 t/o Pension provisions 6,988 7,024 8,973 8,973 10,598 t/o Interest bearing 41,482 52,082 54,947 62,070 61,237 t/o Deferred tax 47,120 43,915 34,706 34,706 33,740 t/o other 0 0 7,123 0 0 ST Liab. < 1 year 180,343 202,859 204,523 204,522 180,418 t/o Acc. payable & pre-paymts. 72,384 98,695 106,644 106,644 102,308 t/o Tax payable 7,810 6,124 8,568 8,568 5,035 t/o Bank loans 48,373 53,063 63,429 63,522 59,601 t/o other current liabilties 51,776 44,977 25,882 25,789 13,475 Total Liabilities 277,634 307,290 311,599 311,599 287,372 Balance Sheet Total 371,611 405,764 405,058 405,058 371,720 Source: HANSA GROUP AG, BankM Research

- 6/8 - Important information, disclosures and disclaimer 23. December 2013 Important information, disclosures and disclaimer A. Important information Equity investments generally involve high risks. Investors may lose some or all of the money invested. Potential investors should take into account that share prices may fall and rise and that income from an investment may fluctuate considerably. Past performance is no guarantee for future results. Investors make their decisions at their own risk. B. Disclosures according to Section 34b of the German Securities Trading Act (WpHG) and the Ordinance on the Analysis of Financial Instruments (FinAnV): I. Information about author, company held accountable, regulatory authority: Responsible for the content of this document: biw Bank für Investments und Wertpapiere AG, Willich, Germany. Authors: Dr. Roger Becker, CEFA and David Szabadvari, Analysts Regulatory authority for biw Bank für Investments und Wertpapiere AG is the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin), Graurheindorfer Straße 108, 53117 Bonn, Germany and Lurgiallee 12, 60439 Frankfurt am Main, Germany. Issuer of the analyzed instruments is HANSA GROUP AG. Notice according to sec. 4. 4 N o 4 FinAnV (previous publications regarding the issuer within the last 12 months): II. Additional Information: Analysts Date Evaluation result Fair value Dr. Roger Becker, David Szabadvari November 19,.2013 no valuation n.a. 1. Sources of information: Main sources of information for the compilation of this document are publications in national and international media and information services (e.g. Reuters, VWD, Bloomberg, dpa-afx and others), financial newspapers and magazines (e.g. Börsenzeitung, Handelsblatt, Frankfurter Allgemeine Zeitung, Financial Times and others), specialist media, published statistics, rating agencies as well as publications by peer group companies and the company itself. Furthermore talks with the management of the issuer have been held. This document was made available to the issuer before publication to ensure the accuracy of the information provided. This resulted in some textual changes. 2. Summary of the valuation principles and methods used to prepare this document: BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG uses a 3-tier absolute rating model. The ratings are the evaluation results and refer to a fair value pricing reflecting a time-horizon of up to 12 months. BUY: The calculated fair value of the company s stock is at least 15 % higher than the current market price at the time of the compilation of this document. NEUTRAL: The calculated fair value of the company s stock lies between 15% and +15 % of the current market price at the time of the compilation of this document. SELL: The calculated fair value of the company s stock is at least 15 % lower than the current market price at the time of the compilation of this document. The following valuation methods are being used: Multiple-based models (Price/Earnings, Price/Cash-flow, Price/Book value, EV/Sales, EV/EBIT, EV/EBITA, EV/EBITDA), peer-group comparisons, historical valuation approaches, discount models (DCF, DDM), break-up value and sum-of-the-parts-approaches, assetbased evaluation methods or a combination of the above. The used valuation models depend on macroeconomic factors, such as interest rates, exchange rates, raw materials and on basic assumptions about the economy. Additionally, market sentiment affects the valuation of companies. The valuation is also based on expectations that might change rapidly and without notice, depending on developments specific to individual industries. Rendered evaluation results and fair values derived from the models might therefore change respectively. The evaluation results in general relate to a 12-month horizon. However, evaluation results are subject to changing market conditions and represent only the situation at a given point of time. The evaluation results and fair value prices may in fact be achieved more quickly or slowly than expected by the analysts. Also, the evaluation results and fair value prices might need to be revised upward or downward. 3. Date of first publication of this document: December 23, 2013 4. Date and time of prices of the instruments quoted in this document: Closing prices of December 20, 2013 5. Updates: A specific date or time for an update of this document has not been set. The information given in this document reflects the author s judgement on the date of this publication and is subject to change without notice; it may be incomplete or condensed and it may not contain all material information concerning the company covered. It is in the sole responsibility of BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG to decide on a potential update of this document. III. Disclosures about potential conflicts of interest: 1. BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG s business model is based on economic relationships with issuers and equity transactions to be performed relating to the issuer s stock. BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG has entered into an agreement about the preparation of this document with the issuer that is, or whose financial instruments are, the subject of this document.

23. Dezember 2013 Important information, disclosures and disclaimer - 7/8 - BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG (incl. subsidiaries and affiliates) as well as tied agents of biw Bank für Investments und Wertpapiere AG in connection with the activities of BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG, the authors of this document as well as other persons that were involved in the compilation of this document or affiliated parties: do not have a major shareholding (shareholding exceeding 5%) of the share capital of the issuer, have not, within the past twelve months, participated in leading a consortium for the issue via public offer of the financial instruments that are, or whose issuers are, the subject of this document, have not, within the past twelve months, been party to an agreement on the provision of investment banking services with the issuer that is, or whose financial instruments are, the subject of this document, or have received services or a promise to perform under the terms of such an agreement during the same period, have no other significant economic interests relating to the issuer that is, or whose financial instruments are, the subject of this analysis. 2. In the function as a designated sponsor, BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG manages the financial instruments that are, or whose issuers are, the subject of the financial analysis on a market by placing buy or sell orders and will regularly hold a trading stock or long or short positions in the issuer s stock. 3. BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG s internal organization is aligned with the prevention of conflict of interests in producing and distributing research reports. Possible conflicts of interests will be treated adequately. In particular, physical and non-physical boundaries were installed to keep analysts from gaining access to information that possibly could constitute a conflict of interest for the bank. biw Bank für Investments und Wertpapiere AG keeps insider registers according to sec. 15 WpHG for employees and assignees that normally have access to inside information. These registers will be transmitted to BaFin on request. Insiders dealings according to sec. 14 WpHG categorically are prohibited. Staff members that fill a specific position and have access to inside information categorically have to disclose all dealings in financial instruments to the internal compliance department. The compliance of legal requirements and supervisory regulations is subject to continuous supervision and control of the compliance department of biw Bank für Investments und Wertpapiere AG. In this regard, the right to restrict employees dealings in financial instruments is reserved. 4. The remuneration of the analysts mentioned above is not dependent on any investment banking transactions of BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG or its affiliates. The analysts that compiled this document did not receive or acquire shares in the issuer that is, or whose financial instruments are, the subject of this document at any time. The analysts mentioned above herby certify that all of the views expressed accurately reflect his or her personal views about the issuer and that no part of his or her compensation was, is or will be, directly or indirectly, related to the specific evaluation result or views expressed by the analyst in this document. 5. Updated information according to sec. 5 para. 4 No. 3 FinAnV is available at: http://www.bankm.de/webdyn/138_cs_gesetzliche+angaben.html. C. Disclaimer This document was compiled by BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG solely for informational purposes and for the personal use by persons in Germany that are interested in the company and who purchase or sell transferable securities for their own account or the account of others in the context of their trade, profession or occupation. This document neither constitutes a contract nor any kind of obligation. This document and its content, in whole or in part, may not be reproduced, distributed, published or passed on to any other person without the prior written consent of BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG. This publication is for distribution in or from the United Kingdom only with the prior written consent of BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG and only to persons who are authorized persons or exempted persons within the meaning of the Financial Services and Markets Act 2000 of the United Kingdom or any order made there under or to investment professionals as defined in Section 19(5) of the Financial Services and Markets Act 2000 (financial promotion) order 2005 (the order) respectively in the version as amended from time to time and is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. Neither this document nor any copy of it may be taken or transmitted into the United States of America, Canada, Japan or Australia or distributed, directly or indirectly, in the United States of America, Canada, Japan or Australia or to any resident thereof. The distribution of this document in other jurisdictions may be restricted by law, and persons who are in possession of this document have to inform themselves about any such restrictions and observe any such restrictions. This document is not intended to be an offer, or the solicitation of any offer, or any advice or recommendation to buy or sell the securities referred to herein. This document is intended to provide information to assist institutional investors in making their own investment decisions, not to provide investment advice to any specific investor. Potential investors should seek professional and individual advice before making their investment decisions. Investment decisions must not be based on this document. The information within this document has been obtained from sources believed by BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG to be reliable, but BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG does not examine the information to be accurate and complete, nor guarantees its accuracy and completeness. Although due care has been taken in compiling this document, it cannot be excluded that the information given is incomplete or the document contains errors. The liability of BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG shall be restricted to gross negligence and wilful misconduct. All opinions expressed in this document are those of BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG respectively the authors and subject to change without notice. Possible errors or incompleteness of this document may be corrected by BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG and do not constitute grounds for liability, neither with regard to indirect nor to direct or consequential damages. Only in case of failure in essential tasks, BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG is liable for simple negligence. In addition BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG does not accept any liability or responsibility for any loss arising from any use of this publication or its contents or otherwise arising in connection herewith. In any case, the liability of BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG is limited to typical, foreseeable damages and the liability for any indirect damages is excluded. By accepting this document, the reader/user of this document agrees to be bound by all of the foregoing provisions and this disclaimer. Moreover, the user agrees not to distribute this document to unauthorized persons. The user of this document shall indemnify BankM Repräsentanz der biw Bank für Investments und Wertpapiere AG for any damages, claims, losses, and detriments resulting from or in connection with the unauthorized use of this document.

- 8/8 - Important information, disclosures and disclaimer 23. December 2013 This document is subject to the laws of the Federal Republic of Germany. Place of jurisdiction is Frankfurt am Main, Germany. Should certain specifications of this disclaimer not be legally binding or become legally non-binding, this will have no impact on the legally binding character of this disclaimer and its other legal specifications. This document is not intended for use by persons resident in any jurisdiction that regulates access to such documents by applicable laws. Investment decisions must not be based on any statement in this document. Persons in possession of this document should inform themselves about possible legal restrictions and observe them accordingly. In case of uncertainty persons should not access and/or consider the content of this document in any decisions. This document is not intended for use by persons that are classified as US-persons under the United States Securities Act. 2013 BankM - Repräsentanz der biw Bank für Investments und Wertpapiere AG, Mainzer Landstraße 61, D-60329 Frankfurt. biw Bank für Investments und Wertpapiere AG, Hausbroicher-Straße 222, D-47877 Willich. All rights reserved. This document is a translation of the legally binding German original version of December 23, 2013.